SP-2-225 is a selective HDAC6 inhibitor. SP-2-225 enhance the production of cancer-associated antigens and macrophage antigen cross-presentation to T cells. SP-2-225 reduces the tumor volume in a syngeneic SM1 melanoma model[1].
Molecular Weight:
446.58
CAS Number:
[2364448-93-9]
Formula:
C28H34N2O3
Target:
HDAC
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted